Summary
Three-year data from the Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Metformin Alone or in Combination With Sulfonylurea trial [DURATION-3; NCT00641056] have confirmed previously reported 26- and 84-week results demonstrating the superiority of the exenatide regimen for glycemic and weight control, and lowered risk of hypoglycemia [Diamant M et al. Lancet 2010; Diamant M et al. Diabetes Care 2012].
- Diabetes Mellitus
- Hyperglycemia/Hypoglycemia Diabetes & Endocrinology Clinical Trials
- Insulin
- Diabetes Mellitus
- Hyperglycemia/Hypoglycemia
- Endocrinology
- Diabetes & Metabolic Syndrome
- Diabetes & Endocrinology Clinical Trials
- Insulin
- © 2013 MD Conference Express®
Tools
Table of contents
Cited By...
- No citing articles found.